Cargando…
Inhaled sphingosine has no adverse side effects in isolated ventilated and perfused pig lungs
Ex-vivo lung perfusion (EVLP) systems like XVIVO are more and more common in the setting of lung transplantation, since marginal donor-lungs can easily be subjected to a performance test or be treated with corticosteroids or antibiotics in high dose regimes. Donor lungs are frequently positive in br...
Autores principales: | Carstens, Henning, Kalka, Katharina, Verhaegh, Rabea, Schumacher, Fabian, Soddemann, Matthias, Wilker, Barbara, Keitsch, Simone, Sehl, Carolin, Kleuser, Burkhard, Wahlers, Thorsten, Reiner, Gerald, Koch, Achim, Rauen, Ursula, Gulbins, Erich, Kamler, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452622/ https://www.ncbi.nlm.nih.gov/pubmed/34545108 http://dx.doi.org/10.1038/s41598-021-97708-3 |
Ejemplares similares
-
Antimicrobial effects of inhaled sphingosine against Pseudomonas aeruginosa in isolated ventilated and perfused pig lungs
por: Carstens, Henning, et al.
Publicado: (2022) -
Sphingosine-coating of plastic surfaces prevents ventilator-associated pneumonia
por: Seitz, Aaron P., et al.
Publicado: (2019) -
Reduced Sphingosine in Cystic Fibrosis Increases Susceptibility to Mycobacterium abscessus Infections
por: Schnitker, Fabian, et al.
Publicado: (2023) -
Interferon regulatory factor 8 regulates expression of acid ceramidase and infection susceptibility in cystic fibrosis
por: Gardner, Aaron Ions, et al.
Publicado: (2021) -
Sphingosine as a New Antifungal Agent against Candida and Aspergillus spp.
por: Hashemi Arani, Fahimeh, et al.
Publicado: (2022)